小细胞

xiǎo xì bāo
  • Small cells;minicell
小细胞小细胞
  1. 结果56例原发性肺癌患者中39例端粒酶活性明显升高,阳性率达696%,其中小细胞肺癌和鳞癌端粒酶活性表达阳性率较高,而腺癌较低。

    Results Blood TLMA activity were significantly high in 39 lung cancer patients , and the positive rate was 69.6 % . The positive rate of TLMA activity in minicell and squamous type lung cancer was higher than that of adenocarcinoma .

  2. 小细胞肺癌是神经内分泌肿瘤,起源于apud(胺前体摄取脱羧化)细胞。

    Small cell lung cancer is neuroendocrine neoplasm and origins from apud ( amine precursor uptake decarboxylation ) cell .

  3. 大部分小细胞肺癌属于燕麦细胞癌。

    Most small cell lung cancers are the oat cell type .

  4. 非小细胞肺癌血管生成的MR动态增强研究

    Clinical Study of Tumor Angiogenesis with Dynamic Contrast-enhanced MR Imaging in Non-small-Cell-Lung-Cancer

  5. 一例ⅡB期非小细胞肺癌术后患者的循证治疗

    Evidence-based Treatment for a Patient of ⅱ B Stage Non-Small Cell Lung Cancer

  6. 可切除Ⅲ期N2非小细胞肺癌治疗共识与争议

    Controversy in The Treatment of Resectable Stage ⅲ - N2 Non-small Cell Lung Cancer

  7. X刀立体定向放射治疗非小细胞肺癌的临床研究

    Clinical study on treatment of non-small cell lung cancer with X-knife stereotactic radiotherapy

  8. 云锡矿工非小细胞肺癌形态计量和DNA定量检测研究

    Cellular morphometry and DNA content measurements of non-small-cell lung cancer of miners in Yunnan Tin Mine

  9. 非小细胞肺癌p53基因治疗的循证医学评价

    Evidence-based Appraisal of p53 Gene Therapy for Non-Small Cell Lung Cancer

  10. 非小细胞肺癌的CT增强值与p53表达的关系研究

    The Relationship between CT Enhancement Value and p53 Protein Expression in Nonsmall cell Lung Cancer

  11. 方法应用CAS&200型图像细胞仪对22例非小细胞肺癌纤支镜活检标本和相应手术标本进行DNA含量分析和比较研究。

    Methods DNA content of bronchoscopic biopsy specimens and corresponding surgical specimens was measured by using CAS-200 image cytometry .

  12. CT引导下的肺部结节针吸活检结果为非小细胞肺癌。

    CT-guided fine-needle aspiration of a lung nodule revealed cells consistent with non – small-cell carcinoma of the lung .

  13. PET与EP/CE方案化疗治疗广泛期小细胞肺癌的疗效比较

    Efficacy of PET and EP / CE Chemotherapy for Extensive Small Cell Lung Cancer

  14. 非小细胞肺癌转移预测指标的Logistic回归分析

    Logistic Regression of Prognostic Prediction of Metastasis in Patients with Non-Small Cell Lung Cancer

  15. 非小细胞肺癌动态CT增强值与正电子发射计算机体层摄影脱氧葡萄糖标准摄取值的相关性探讨

    Correlative investigation of dynamic contrast CT and positron emission tomography with 18-fluorodeoxy glucose standardized uptake value in non-small cell lung cancer

  16. 国产药VC方案与GC方案治疗晚期非小细胞肺癌的对比观察

    Comparative Study of VC and GC Regimen in Advanced Stage Nonsmall Cell lung Cancer

  17. 实时荧光定量PCR及免疫组化检测非小细胞肺癌中Survivin表达及意义

    Real-time PCR and Immunohistochemistry Detecting the Expression of Survivin in NSCLC and the Clinical Significance

  18. 非小细胞肺癌PCNA、ki-67和p53表达的研究

    Expression of PCNA 、 Ki-67 and P53 in Nonsmall Cell Lung Cancer

  19. 非小细胞性肺癌微血管密度和P53蛋白的检测及其临床意义

    Detection of microvessel density and P53 protein expression and their clinical significance in non-small cell lung cancer

  20. 目的探讨肝素酶基因及血管内皮生长因子(VEGF)在非小细胞肺癌(NSCLC)中的表达及其临床病理学意义。

    Objective To study the clinicopathological significance of heparanase and VEGF expression in NSCLC .

  21. vEGFmRNA、KDRmRNA及蛋白在非小细胞肺癌中表达的意义探讨

    Significance of expression of VEGF mRNA , KDR mRNA and corresponding proteins in non-small cell lung cancer

  22. 口服VP(16)联合DDP方案治疗非小细胞肺癌

    Oral VP 16 Plus DDP Regimen for Non small Cell Lung Cancer

  23. 非小细胞肺癌组织中KAI1/CD(82)和P53的表达及临床意义

    Expression and clinicopathologic significance of KAI1 / CD_ ( 82 ) and P53 gene protein in Non-small cell lung cancer

  24. EGFR突变与非小细胞肺癌酪氨酸激酶抑制剂靶向治疗

    EGFR mutations and targeted therapy with tyrosine kinases inhibitors in non-small cell lung cancer

  25. 方法:将40例晚期(Ⅲb期、Ⅳ期)非小细胞肺癌患者随机分为2组,均使用NP化疗方案。

    Methods : 40 cases of ⅲ b and ⅳ stage of NSCLC were allocated to 2 groups randomly with NP chemotherapy programme .

  26. 在B5原生质体培养基中,A(11)B2的原生质体再生细胞形成小细胞团;

    When protoplasts isolated from callus line A_ ( 11 ) B_2 were cultured on the modified B_ (?) medium , cell division was arrested at the stage of cell clusters .

  27. 小细胞肺癌血清NSE、CIC、CEA检测的临床意义

    The clinic value of serum NSE , cic and CEA in small cell lung cancer

  28. COX-2可能通过促进肿瘤的血管和淋巴管形成而参与了非小细胞肺癌细胞的浸润和转移。

    COX-2 may participate in the metastasis of non-small cell lung cancer through promoting vascularization in the tumors .

  29. 非小细胞肺癌病灶中p53、ki-67以及p21的表达和淋巴结微转移灶之间的关系

    Relationship Between p53 , ki-67 , p21 and Micrometastasis in Lymph nodes of Patients with Non-small-cell Lung Cancer

  30. 川陈皮素对非小细胞肺癌A549细胞株的抑制作用及作用机理的研究

    The Mechanism of Inhibitory Effect of Nobiletin on Human Non-small Cell Lung Cancer Cell Line A549